Zimbabwe Pharmaceuticals & Healthcare Q3 2018
Zimbabwe’s small pharmaceutical market and under-funded healthcare sector offer few opportunities to multinationaldrugmakers. Demand for innovative medicines will remain limited by the country’s demographics and epidemiological profile, wherea high prevalence of HIV/AIDS contributes to short life expectancy and low non-communicable disease burden. This profile willbenefit generic drugmakers operating in the country over the long-term, especially as the population grows. However, Zimbabwe isstill largely dependent on foreign medical aid, undermining the growth potential of the pharmaceutical market for local firms.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook